Ikarian Capital »

Verve Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $959k 170k 5.64
2024-09-30 $823k 170k 4.84
2023-12-31 $576k 41k 13.94
2023-09-30 $5.9M 4.4k 1326.00

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Verve Therapeutics

Alphabet
BlackRock
BVF
Vanguard Group
Casdin Capital
Millennium Management
Schonfeld Strategic Advisors
State Street Corporation
T. Rowe Price Investment Management
Novo A/S
Arch Venture Corp
Jacobs Levy Equity Management
Baker Bros. Advisors
Geode Capital Management
FMR

View all funds holding Verve Therapeutics